MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
Recruiting · NCT05978466 · Observational (researchers observe without assigning treatment) · Lead sponsor: CorVita Science Foundation
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this research is to learn more about the normal care of patients with a new or pre-existing diagnosis of atrial fibrillation (AF). These abnormal and irregular heartbeats place patients at increased risk of developing clots in their bloodstream that could potentially lead to stroke. Normal care is designed to help prevent this from happening and to lessen or eliminate the symptoms patients may have. There are many different types of AF as well as numerous ways in which a variety of patients are treated. The investigators are interested in gathering more information to better keep track of patient treatment patterns (trends) that may differ from physician to physician, hospital to hospital, medication to medication, patient to patient and if necessary, procedure to procedure.
Who can take part
Inclusion criteria
- Diagnosis of valvular or non valvular atrial fibrillation
- ECG documented atrial fibrillation A. 12 lead B. Rhythm strip C. Event monitor D. Holter Monitor E. Implantable loop recorder
Exclusion criteria
- Age below 18 years.
- Clinical evidence that death within 6 months is possible
- Inability to consent to the research or sign a consent form
- Inability to follow up at the research clinic at least annually for continuity of AF care and management
Where it is running
1 location listed across 1 US state.
- CorVita Science Foundation (NFP) - Chicago, Illinois, United States